Reactive Oxygen Species, Oxidative Stress, and Vascular Biology in Hypertension

Comprehensive Hypertension

Volumn , Issue , 2007, Pages 337-347

  Tabet, Fatiha ^a   Touyz, Rhian M ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959822188     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-03961-1.50033-7     Document Type: Chapter

References (171)

1. I Fridovich (1997) Superoxide anion radical (O2-), superoxide dismutases, and related matters. J Biol Chem 272(30), 18515.
2. CF Mueller, K Laude, JS McNally and DG Harrison (2005) ATVB in focus: redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol 25(2), 274.
3. JI Mendez, WJ Nicholson and WR Taylor (2005) SOD isoforms and signaling in blood vessels: evidence for the importance of ROS compartmentalization. Arterioscler Thromb Vasc Biol 25(5), 887.
4. AM Zafari, M Ushio-Fukai, M Akers, et al. (1998) Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 32(3), 88. 4
5. RM Touyz and EL Schiffrin (2004) Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 122(4), 339.
6. KK Griendling, D Sorescu and M Ushio-Fukai (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86(5), 494.
7. RM Touyz, X Chen, F Tabet, et al. (2002) Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 90(11), 1205.
8. I Fleming, UR Michaelis, D Bredenkotter, et al. (2001) Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res 88(1), 44.
9. KM Channon and TJ Guzik (2002) Mechanisms of superoxide production in human blood vessels, relationship to endothelial dysfunction, clinical and genetic risk factors. J Physiol Pharmacol 53(4 Pt 1), 515.
10. SA Jones, VB O'Donnell, JD Wood, et al. (1996) Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol 271(4 Pt 2), H1626.
11. FE Rey and PJ Pagano (2002) The reactive adventitia: fibroblast oxidase in vascular function. Arterioscler Thromb Vasc Biol 22(12), 1962.
12. DG Harrison (1997) Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100(9), 2153.
13. RM Touyz (2004) Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44(3), 248.
14. S Rajagopalan, S Kurz, T Munzel, et al. (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97(8), 1916.
15. NE Taylor and AW Cowley Jr (2005) Effect of renal medullary H2O2 on salt-induced hypertension and renal injury. Am J Physiol Regul Integr Comp Physiol 289 R277. (Epub ahead of print)
16. WJ Welch, M Mendonca, J Blau, et al. (2005) Antihypertensive response to prolonged tempol in the spontaneously hypertensive rat. Kidney Int 68(1), 179.
17. A Fratta Pasini, U Garbin, MC Nava, et al. (2005) Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation. J Hypertens 23(3), 589.
18. RD Manning Jr, N Tian and S Meng (2005) Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol 25(4), 311.
19. D Sorescu, D Weiss, B Lassegue, et al. (2002) Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105(12), 1429.
20. C Berry, CA Hamilton, MJ Brosnan, et al. (2000) Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 101(18), 2206.
21. CS Wilcox and D Gutterman (2005) Focus on oxidative stress in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 288(1), H3.
22. H Cai (2005) NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res 96(8), 818.
23. GM Bokoch and UG Knaus (2003) NADPH oxidases: not just for leukocytes anymore. Trends Biochem Sci 28(9), 502.
24. BM Babior, JD Lambeth and W Nauseef (2002) The neutrophil NADPH oxidase. Arch Biochem Biophys 397(2), 342.
25. KA Gauss, PL Mascolo, DW Siemsen, et al. (2002) Cloning and sequencing of rabbit leukocyte NADPH oxidase genes reveals a unique p67(phox) homolog. J Leukoc Biol 71(2), 319.
26. JW Park, M Ma, JM Ruedi, et al. (1992) The cytosolic components of the respiratory burst oxidase exist as a M(r) approximately 240,000 complex that acquires a membrane-binding site during activation of the oxidase in a cell-free system. J Biol Chem 267(24), 17327.
27. RM Touyz, G Yao, MT Quinn, et al. (2005) p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II. Arterioscler Thromb Vasc Biol 25(3), 512.
28. J el Benna, JM Ruedi and BM Babior (1994) Cytosolic guanine nucleotide-binding protein Rac2 operates in vivo as a component of the neutrophil respiratory burst oxidase. Transfer of Rac2 and the cytosolic oxidase components p47phox and p67phox to the submembranous actin cytoskeleton during oxidase activation. J Biol Chem 269(9), 6729.
29. SS Iyer, DW Pearson, WM Nauseef, et al. (1994) Evidence for a readily dissociable complex of p47phox and p67phox in cytosol of unstimulated human neutrophils. J Biol Chem 269(35), 22405.
30. AR Cross and JT Curnutte (1995) The cytosolic activating factors p47phox and p67phox have distinct roles in the regulation of electron flow in NADPH oxidase. J Biol Chem 270(12), 6543.
31. B Lassegue and RE Clempus (2003) Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285(2), R277.
32. RM Touyz, G Yao and EL Schiffrin (2003) c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23(6), 981.
33. YA Suh, RS Arnold, B Lassegue, et al. (1999) Cell transformation by the superoxide-generating oxidase Mox1. Nature 401(6748), 79.
34. LL Hilenski, RE Clempus, MT Quinn, et al. (2004) Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24(4), 677.
35. T Ago, T Kitazono, H Ooboshi, et al. (2004) Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109(2), 227.
36. IR Hanna, LL Hilenski, A Dikalova, et al. (2004) Functional association of noxl with p22phox in vascular smooth muscle cells. Free Radic Biol Med 37(10), 1542.
37. B Banfi, RA Clark, K Steger and KH Krause (2003) Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem 278(6), 3510.
38. R Takeya, N Ueno, K Kami, et al. (2003) Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases. J Biol Chem 278(27), 25234.
39. G Cheng and JD Lambeth (2005) Alternative mRNA splice forms of NOXOl: Differential tissue expression and regulation of Noxl and Nox3. Gene 356 118-126.
40. RJ Bolterman, MC Manriquez, MC Ortiz Ruiz, et al. (2005) Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Hypertension 46 943. (Epub ahead of print)
41. X Chen, RM Touyz, JB Park and EL Schiffrin (2001) Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38(3 Pt 2), 606.
42. N Kobayashi, FA Delano and GW Schmid-Schonbein (2005) Oxidative stress promotes endothelial cell apoptosis and loss of microvessels in the spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 25 2114.
43. RM Touyz and EL Schiffrin (2001) Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens 19(7), 1245.
44. S Wassmann, K Wassmann and G Nickenig (2004) Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 44(4), 381.
45. U Landmesser, H Cai, S Dikalov, et al. (2002) Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40(4), 511.
46. D Harrison, KK Griendling, U Landmesser, et al. (2003) Role of oxidative stress in atherosclerosis. Am J Cardiol 91(3A), 7A.
47. JS McNally, A Saxena, H Cai, et al. (2005) Regulation of xanthine oxidoreductase protein expression by hydrogen peroxide and calcium. Arterioscler Thromb Vasc Biol 25(8), 1623.
48. CE Berry and JM Hare (2004) Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555(Pt 3), 589.
49. H Suzuki, FA DeLano, DA Parks, et al. (1998) Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci U S A 95(8), 4754.
50. M Minami, A Ishiyama, M Takagi, et al. (2005) Effects of allopurinol, a xanthine oxidase inhibitor, on renal injury in hypercholesterolemia-induced hypertensive rats. Blood Press 14(2), 120.
51. C Cardillo, CM Kilcoyne, RO Cannon 3rd, et al. (1997) Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension 30(1 Pt 1), 57.
52. S Spiekermann, U Landmesser, S Dikalov, et al. (2003) Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 107(10), 1383.
53. BD Fink, KJ Reszka, JA Herlein, et al. (2005) Respiratory uncoupling by UCP1 and UCP2 and superoxide generation in endothelial cell mitochondria. Am J Physiol Endocrinol Metab 288(1), E71.
54. MH Ali, DP Pearlstein, CE Mathieu and PT Schumacker (2004) Mitochondrial requirement for endothelial responses to cyclic strain: implications for mechanotransduction. Am J Physiol Lung Cell Mol Physiol 287(3), L486.
55. N Li, K Ragheb, G Lawler, et al. (2003) Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem 278(10), 8516.
56. P Puddu, GM Puddu, L Galletti, et al. (2005) Mitochondrial dysfunction as an initiating event in atherogenesis: a plausible hypothesis. Cardiology 103(3), 137.
57. RM Touyz, G Yao, E Viel, et al. (2004) Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J Hypertens 22(6), 1141.
58. Y Xia, VL Dawson, TM Dawson, et al. (1996) Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A 93(13), 6770.
59. J Vasquez-Vivar, B Kalyanaraman, P Martasek, et al. (1998) Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A 95(16), 9220.
60. J Vasquez-Vivar, B Kalyanaraman and P Martasek (2003) The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications. Free Radic Res 37(2), 121.
61. LJ Dixon, SM Hughes, K Rooney, et al. (2005) Increased superoxide production in hypertensive patients with diabetes mellitus: role of nitric oxide synthase. Am J Hypertens 18(6), 839.
62. ZS Katusic (2001) Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? Am J Physiol Heart Circ Physiol 281(3), H981.
63. U Landmesser, S Dikalov, SR Price, et al. (2003) Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111(8), 1201.
64. U Landmesser and DG Harrison (2001) Oxidative stress and vascular damage in hypertension. Coron Art Dis 12 455.
65. B Fisslthaler, R Popp, L Kiss, et al. (1999) Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401(6752), 493.
66. S Puntarulo and A. Cederbaum Al (1998) Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes. Free Radic Biol Med 24(7–8), 1324.
67. I Fleming, UR Michaelis, D Bredenkotter, et al. (2001) Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res 88(1), 44.
68. P Stralin, K Karlsson, BO Johansson and SL Marklund (1995) The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 15(11), 2032.
69. Halliwell B: Antioxidant defence mechanisms, from the beginning to the end (of the beginning) Free Radic Res, 31 (4): 261.
70. FM Faraci and SP Didion (2004) Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol 24(8), 1367.
71. T Fukai, RJ Folz, U Landmesser and DG Harrison (2002) Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res 55(2), 239.
72. V Jeney, S Itoh, M Wendt, et al. (2005) Role of antioxidant-1 in extracellular superoxide dismutase function and expression. Circ Res 96(7), 723.
73. HN Kirkman, M Rolfo, AM Ferraris and GF Gaetani (1999) Mechanisms of protection of catalase by NADPH. Kinetics and stoichiometry. J Biol Chem 274(20), 13908.
74. GF Gaetani, AM Ferraris, P Sanna and HN Kirkman (2005) A novel NADPH: (bound) NADP+ reducíase and NADH: (bound) NADP+ transhydrogenase function in bovine liver catalase. Biochem J 385(Pt 3), 763.
75. S Ulker, D McMaster, PP McKeown and U Bayraktutan (2003) Impaired activities of antioxidant enzymes elicit endothelial dysfunction in spontaneous hypertensive rats despite enhanced vascular nitric oxide generation. Cardiovasc Res 59(2), 488.
76. FQ Schafer and GR Buettner (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30(11), 1191.
77. R Schnabel, KJ Lackner, HJ Rupprecht, et al. (2005) Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study. J Am Coll Cardiol 45(10), 1631.
78. JC Whitin, S Bhamre, DM Tham and HJ Cohen (2002) Extracellular glutathione peroxidase is secreted basolaterally by human renal proximal tubule cells. Am J Physiol Renal Physiol 283(1), F20.
79. JA Leopold and J Loscalzo (2005) Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol 25(7), 1332.
80. C Bierl, B Voetsch, RC Jin, et al. (2004) Determinants of human plasma glutathione peroxidase (GPx-3) expression. J Biol Chem 279(26), 26839.
81. H Yamawaki and BC Berk (2005) Thioredoxin: a multifunctional antioxidant enzyme in kidney, heart and vessels. Curr Opin Nephrol Hypertens 14(2), 149.
82. H Nakamura (2005) Thioredoxin and its related molecules: update. Antioxid Redox Signal 7(5–6), 823.
83. S Immenschuh and E Baumgart-Vogt (2005) Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal 7(5–6), 768.
84. M Okuda, N Inoue, H Azumi, et al. (2001) Expression of glutaredoxin in human coronary arteries, its potential role in antioxidant protection against atherosclerosis. Arterioscler Thromb Vasc Biol 21 1483.
85. KC Das, Y Lewis-Molock and CW White (1997) Elevation of manganese superoxide dismutase gene expression by thioredoxin. Am J Respir Cell Mol Biol 17(6), 713.
86. M Tanito, H Nakamura, YW Kwon, et al. (2004) Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats. Antioxid Redox Signal 6(1), 89.
87. Z Jiang, JM Akey, J Shi, et al. (2001) A polymorphism in the promoter region of catalase is associated with blood pressure levels. Hum Genet 109(1), 95.
88. MA Forgione, N Weiss, S Heydrick, et al. (2002) Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am J Physiol Heart Circ Physiol 282(4), H1255.
89. K Ono, T Mannami and N Iwai (2003) Association of a promoter variant of the heme oxygenase-1 gene with hypertension in women. J Hypertens 21 1497.
90. RS Gaskin, D Estwick and R Peddi (2001) G6PD deficiency its role in the high prevalence of hypertension and diabetes mellitus. Ethn Dis 11(4), 749.
91. MA Forgione, J Loscalzo, M Holbrook, et al. (2003) The A326G (A+) variant of the glucose-6-phosphate dehydrogenase gene is associated with endothelial dysfunction in African Americans. J Am Coll Cardiol 41 249A.
92. MW McBride, MJ Brosnan, J Mathers, et al. (2005) Reduction of Gstm1 expression in the stroke-prone spontaneously hypertension rat contributes to increased oxidative stress. Hypertension 45(4), 786.
93. AF Dominiczak, D Graham, MW McBride, et al. (2005) Corcoran Lecture. Cardiovascular genomics and oxidative stress. Hypertension 45(4), 636.
94. JJ Haddad (2002) Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal 14(11), 879.
95. RM Touyz, M Cruzado, F Tabet, et al. (2003) Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. Can J Physiol Pharmacol 81(2), 159.
96. F Tabet, C Savoia, EL Schiffrin and RM Touyz (2004) Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol 44(2), 200.
97. K Laude, H Cai, B Fink, et al. (2005) Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice. Am J Physiol Heart Circ Physiol 288(1), H7.
98. A Dikalova, R Clempus, B Lassegue, et al. (2005) Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112 2668-2676.
99. KK Griendling, D Sorescu, B Lassegue and M Ushio-Fukai (2000) Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20(10), 2175.
100. NN Deshpande, D Sorescu, P Seshiah, et al. (2002) Mechanism of hydrogen peroxide-induced cell cycle arrest in vascular smooth muscle. Antioxid Redox Signal 4(5), 845.
101. AE Li, H Ito, II Rovira, et al. (1999) A role for reactive oxygen species in endothelial cell anoikis. Circ Res 85(4), 304.
102. NR Madamanchi, SK Moon, ZS Hakim, et al. (2005) Differential activation of mitogenic signaling pathways in aortic smooth muscle cells deficient in superoxide dismutase isoforms. Arterioscler Thromb Vasc Biol 25 950.
103. S Rajagopalan, XP Meng, S Ramasamy, et al. (1996) Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98(11), 2572.
104. M Sundaresan, ZX Yu, VJ Ferrans, et al. (1995) Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270(5234), 296.
105. BV Khan, DG Harrison, MT Olbrych, et al. (1996) Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci U S A 93 9114.
106. RW Alexander (1995) Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 25(2), 155.
107. M Usui, K Egashira, H Tomita, et al. (2000) Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats. Circulation 101 305.
108. GW De Keulenaer, M Ushio-Fukai, Q Yin, et al. (2000) Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-alpha-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20(2), 385.
109. Y Han, MS Runge and AR Brasier (1999) Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. Circ Res 84(6), 695.
110. XL Chen, PE Tummala, MT Olbrych, et al. (1998) Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 83(9), 952.
111. Q Li and IM Verma (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2(10), 725.
112. B Kristal, R Shurtz-Swirski, J Chezar, et al. (1998) Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension. Am J Hypertens 11(8 Pt 1), 921.
113. CH Kim and ND Vaziri (2005) Hypertension promotes integrin expression and reactive oxygen species generation by circulating leukocytes. Kidney Int 67(4), 1462.
114. A Fortuno, S Olivan, O Beloqui, et al. (2004) Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension. J Hypertens 22(11), 2169.
115. D Weiss, JJ Kools and WR Taylor (2001) Angiotensin II-induced hypertension accelerates the development of atherosclerosis in ApoE-deficient mice. Circulation 103 448.
116. T Yada, H Shimokawa, O Hiramatsu, et al. (2003) Hydrogen peroxide, an endogenous endothelium-derived hyperpolarizing factor, plays an important role in coronary autoregulation in vivo. Circulation 107(7), 1040.
117. T Matoba, H Shimokawa, M Nakashima, et al. (2000) Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 106(12), 1521.
118. G Torrecillas, MC Boyano-Adanez, J Medina, et al. (2001) The role of hydrogen peroxide in the contractile response to angiotensin II. Mol Pharmacol 59(1), 104.
119. MP Schuijt, B Tom, R de Vries, et al. (2003) Superoxide does not mediate the acute vasoconstrictor effects of angiotensin II: a study in human and porcine arteries. J Hypertens 21(12), 2335.
120. YJ Gao and RM Lee (2001) Hydrogen peroxide induces a greater contraction in mesenteric arteries of spontaneously hypertensive rats through thromboxane A(2) production. Br J Pharmacol 134(8), 1639.
121. RM Touyz (2003) Activated oxygen metabolites: do they really play a role in angiotensin II-regulated vascular tone? J Hypertens 21(12), 2235.
122. D Zhuang, AC Ceacareanu, Y Lin, et al. (2004) Nitric oxide attenuates insulin- or IGF-I-stimulated aortic smooth muscle cell motility by decreasing H 2O 2 levels: essential role of cGMP. Am J Physiol Heart Circ Physiol 286(6), H2103.
123. JB Park, RM Touyz, X Chen and EL Schiffrin (2002) Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am J Hypertens 15(1 Pt 1), 78.
124. L Nabha, JC Garbern, CL Buller and JR Charpie (2005) Vascular oxidative stress precedes high blood pressure in spontaneously hypertensive rats. Clin Exp Hypertens 27 71.
125. T Chabrashvili, A Tojo, ML Onozato, et al. (2002) Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39(2), 269.
126. TM Paravicini, S Chrissobolis, GR Drummond and CG Sobey (2004) Increased NADPH-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo. Stroke 35(2), 584.
127. G Zalba, G San Jose, FJ Beaumont, et al. (2001) Polymorphisms and promoter overactivity of the p22(phox) gene in vascular smooth muscle cells from spontaneously hypertensive rats. Circ Res 88(2), 217.
128. G San Jose, MU Moreno, S Olivan, et al. (2004) Functional effect of the p22phox-930A/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension. Hypertension 44 163.
129. U Kumar, J Chen, V Sapoznikhov, et al. (2005) Overexpression of inducible nitric oxide synthase in the kidney of the spontaneously hypertensive rat. Clin Exp Hypertens 27 17.
130. I Vaneckova, HJ Kramer, J Novotna, et al. (2005) Role of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats. Kidney Blood Press Res 28(2), 117.
131. JB Laursen, S Rajagopalan, Z Galis, et al. (1997) Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95 588.
132. A Virdis, M Fritsch Neves, et al. (2002) Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension 40(4), 504.
133. A Tojo, ML Onozato, N Kobayashi, et al. (2002) Angiotensin II and oxidative stress in Dahl salt-sensitive rat with heart failure. Hypertension 40(6), 834-839.
134. Y Ding, HC Gonick, ND Vaziri, et al. (2001) Lead-induced hypertension. III. Increased hydroxyl radical production. Am J Hypertens 14 169.
135. AD Dobrian, MJ Davies, SD Schriver, et al. (2001) Oxidative stress in a rat model of obesity-induced hypertension. Hypertension 37 554.
136. R Wu, E Millette, L Wu and J de Champlain (2001) Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats. J Hypertens 19(4), 741.
137. M Iglarz, RM Touyz, EC Viel, et al. (2004) Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction with the renin-angiotensin system. Am J Hypertens 17(7), 597.
138. WJ Welch, M Mendonca, S Aslam and CS Wilcox (2003) Roles of oxidative stress and AT1 receptors in renal hemodynamics and oxygenation in the postclipped 2K,1C kidney. Hypertension 41(3 Pt 2), 692.
139. D Javeshghani, RM Touyz, MR Sairam, et al. (2003) Attenuated responses to angiotensin II in follitropin receptor knockout mice, a model of menopause-associated hypertension. Hypertension 42(4), 761.
140. HJ Hong, G Hsiao, TH Cheng and MH Yen (2001) Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension 38(5), 1044.
141. S Kimura, GX Zhang, A Nishiyama, et al. (2005) Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide. Hypertension 45(3), 438.
142. CJ Wallwork, DA Parks and GW Schmid-Schonbein (2003) Xanthine oxidase activity in the dexamethasone-induced hypertensive rat. Microvasc Res 66(1), 30.
143. B Rodriguez-Iturbe, CD Zhan, Y Quiroz, et al. (2003) Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 41(2), 341.
144. WM Ratnayake, L Plouffe, R Hollywood, et al. (2000) Influence of sources of dietary oils on the life span of stroke-prone spontaneously hypertensive rats. Lipids 35(4), 409.
145. AF Dominiczak, D Graham, MW McBride, et al. (2005) Cardiovascular genomics and oxidative stress. Hypertension 45 636.
146. F Lacy, MT Kailasam, DT O'Connor, et al. (2000) Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 36(5), 878.
147. P Minuz, P Patrignani, S Gaino, et al. (2002) Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation 106(22), 2800.
148. MP Stojiljkovic, HF Lopes, D Zhang, et al. (2002) Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster. J Hypertens 20(6), 1215.
149. C Russo, O Olivieri, D Girelli, et al. (1998) Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 16(9), 1267.
150. P Minuz, P Patrignani, S Gaino, et al. (2002) Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation 106 2800.
151. J Redon, MR Oliva, C Tormos, et al. (2003) Anti-oxidant activities and oxidative stress by-products in human hypertension. Hypertension 41 1096.
152. GY Lip, E Edmunds, SL Nuttall, et al. (2002) Oxidative stress in malignant and non-malignant phase hypertension. J Hum Hypertens 16(5), 333.
153. VM Lee, PA Quinn, SC Jennings and LL Ng (2003) Neutrophil activation and production of reactive oxygen species in pre-eclampsia. J Hypertens 21(2), 395.
154. RA Parslow, P Sachdev, C Salonikas, et al. (2005) Associations between plasma antioxidants and hypertension in a community-based sample of 415 Australians aged 60–64. J Hum Hypertens 19(3), 219.
155. NC Ward, JM Hodgson, IB Puddey, et al. (2004) Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle. Free Radic Biol Med 36 226.
156. SJ Duffy, N Gokce, M Holbrook, et al. (1999) Treatment of hypertension with ascorbic acid. Lancet 354 2048.
157. MD Fotheby, JC Williams, LA Forster, et al. (2000) Effect of vitamin C on ambulatory blood pressure and plasma lipids in older patients. J Hypertens 18 411.
158. RM Touyz and EL Schiffrin (2001) Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens 19(7), 1245.
159. RM Touyz, F Tabet and EL Schiffrin (2003) Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clin Exp Pharmacol Physiol 30(11), 860.
160. S Sagar, IJ Kallo, N Kaul, et al. (1992) Oxygen free radicals in essential hypertension. Mol Cell Biochem 111(1–2), 103.
161. P Minuz, P Patrignani, S Gaino, et al. (2004) Determinants of platelet activation in human essential hypertension. Hypertension 43 64.
162. G Germano, V Sanguigni, P Pignatelli, et al. (2004) Enhanced platelet release of superoxide anion in systemic hypertension: role of AT1 receptors. J Hypertens 22(6), 1151.
163. U Rueckschloss, MT Quinn, J Holtz and H Morawietz (2002) Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 22(11), 1845.
164. R Dechend, C Viedt, DN Muller, et al. (2003) AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 107(12), 1632.
165. WJ Welch and CS Wilcox (2001) AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR. Kidney Int 59 1257.
166. EL Schiffrin and RM Touyz (2003) Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade. J Am Coll Cardiol 42(5), 911.
167. DP Vivekananthan, MS Penn, SK Sapp, et al. (2003) Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361(9374), 2017.
168. NG Stephens, A Parsons, PM Schofield, et al. (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347(9004), 781.
169. RM Salonen, K Nyyssonen and J Kaikkomen (2003) Six year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 107 947.
170. HOPE Investigators. (2000) Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 342 154.
171. HOPE-TOO Trial Investigators. (2005) Effects of long-term vitamin E supplementation on cardiovascular events and cancer. A randomized controlled trial. JAMA 293 1338.